Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study
Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study. // eBioMedicine. – URL: https://www.sciencedirect.com/science/article/pii/S2352396426004159?dgcid=rss_sd_all
Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study. eBioMedicine. https://www.sciencedirect.com/science/article/pii/S2352396426004159?dgcid=rss_sd_all
“Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study.” eBioMedicine.
@article{article43812,
title = {Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study},
journal = {eBioMedicine},
url = {https://www.sciencedirect.com/science/article/pii/S2352396426004159?dgcid=rss_sd_all}
}